NDRA - ENDRA Life Sciences receives European patent for TAEUS system
- ENDRA Life Sciences ( NASDAQ: NDRA ) said on Wednesday the European Patent Office had issued Patent for its TAEUS system to calculate fat concentration in the human body with multiple thermoacoustic measurements.
- The company has the same patent protection in the U.S. and China.
- The patent is titled "System for Estimating Fractional Fat Content of an Object."
- The company's Thermo-Acoustic Enhanced UltraSound (TAEUS) combines radio frequency and ultrasound waves to measure fat in the liver.
- "Our portfolio currently features 54 patents issued globally, including eight issued in Europe," the company said.
- ( NDRA ) is trading 5% higher premarket.
For further details see:
ENDRA Life Sciences receives European patent for TAEUS system